This year, Rensselaer Polytechnic Institute researchers will begin work on a radically new approach to treating and preventing genetic diseases such as Alzheimer’s.It’s thanks to a grant from the National Institutes of Health’s TARGETED Challenge, which funds scientific research on ways to deliver gene editing tools directly to cells in the human body. 

For the first time, researchers have used bacteria to “upcycle” waste polyethylene

A team of researchers led by Rensselaer Polytechnic Institute’s Jonathan S. Dordick, Ph.D., Institute Professor of Chemical and Biological Engineering, has illuminated a new possibility for the treatment and prevention of COVID-19 in research published in Communications Biology.

Researchers at Rensselaer Polytechnic Institute (RPI) have published research in Molecular Pharmaceuticals predicting how proteins interact in drug development. The research, funded by the National Science Foundation (NSF), is in collaboration with Amgen and University of Michigan – Ann Arbor. In the paper, researchers use a mathematical model to predict the viscosity of solutions of proteins to be used as drugs. This is critical in drug development as the viscosity determines the method of delivery — needle or IV.